OPPORTUNITIES OF NEUTRON CAPTURE THERAPY IN UZBEKISTAN

In article are presented the devices and characteristics of channel of epithermal neutrons created on nuclear reactor WWR-SM INP AS of RUz for medical and biologic researches. Realized medical and biologic researches on neutroncapture therapy are discussed. Developed for treatment of radio resistant malignant tumors the Gadolinium neutron capture therapy (GdNCT) is based on the nuclear capture and reactions that occur when 155Gd and 157Gd, which are nonradioactive constituents of natural elemental gadolinium, are irradiated by thermal neutrons with low energy 0.025 eV. In this article, results of scientific researches on development GdNCT in Uzbekistan are presented. The beam of epithermal neutrons with characteristics satisfying the all requirements of IAEA was received. Neutron kerma for biological tissues Kbt n=1,35•10–4 Gr/s and for 1 mg natural gadolinium in 1 g of biological tissues KGd n = 3,1•10–7 Gr/s for this beam was calculated. As gadolinium delivery agent the well-known pharmacological preparation Magnevist was chosen. For absorbed dose calculation, the Magnevist pharmacokinetics was studied after intratumoral injection in mice and intramuscular injection in rats. Results of researches of influence epithermal neutrons beam on binding ability of transport proteins of human blood, on tumor cells С-180 at mice and on surgical material of human stomach adenocarcinoma are presented. Planned scientific researches with application of this beam in Uzbekistan are summarized.

neutron capture therapy, radiation therapy, epithermal neutron fluxes, nuclear reactor, gadolinium, magnevist

1. Nuclear medicine. Azu Hku Ma-Imm, 1995, Van Rijk P. P., Van Dongen A. J.

2. Tsyb A.F., Ulyanenko S.E., Mardynskyj Yu.S. Neutrons in malignant tumors treatment. Obninsk, 2003.

3. Abdullaeva G.A., Koblik Yu.N., Kulabdullaev G.A. Reactor VVR-SM using for development of neutron-capture therapy in Uzbekistan. Izvestiya RAN [News of Russian Academy Of Sciences]. 2009. no.4. p.540–543.

4. Burian J., Marek M., Rataj J. et all. The BNCT facility at NRI reactor in the Czech Republic // Proceedings of 7th Int. Symp. on NCT for Cancer, Zurich, September, Elsevier Science, 1996, I, 391–394.

5. Zaitsev K. N., Portnov A. A., Mishcherina O. V.et.al. Neutron capture therapy at MEPhI reactor // International Journal of Nuclear Science and Technology, 2004, 83–101.

6. Soloway A.H. et al. The rationale and requirements for the development of boron neutron capture therapy of brain tumors // J. Neuro-Oncology, 1997, 33, № 1–2.

7. Current Status of NCT. IAEA-TECDOC-1223, IAEA, 2001, Vienna.

8. MCNP — A General Monte Carlo NParticle Code — Version4C.2000.Briestmeister J.F.

9. Auterinen I., Seren T. et al. Measurement of free beam neutrons spectra at eight BNCT facilities worldwide // Applied Radiation and Isotopes, Elsevier Science, 2004, № 61, 1021–1026.

10. Abdullaeva G.A., Koblik Yu.N., Kulabdullaev G.A. Dozing characteristics of epithermal neutron rays. 8th International Conference Nuclear and Radiation Physics, September 20–23, 2011, Almaty, Kazakhstan, Reports, p. 225–228.

11. G. Gambarini, V. Colli, M. Cortesi, U. Danesi, S. Gaya, R. Rosa, G. Rosi Combined utilization of 10B and 157Gd in NCT. Physical measurements. ICNCT-11, Boston, USA, 11–15 October, 2004, p 42–56

12. Kulabdullaev G.A., Abdullaeva G.A., Koblik Yu.N., Saytzhanov Sh.N., Kim A.A., Dzhuraeva G.T. About gadolinium using for investigations of neutron-capture therapy on VVR-SM reactor. Uzbekskyj Fizicheskyj Zhurnal [Uzbek Physical Journal]. 2013. vol.15, no. 5–6, p.292–304.

13. G. L. Locher. Biological effects and therapeutic possibilities of neutrons //American Journal of Roentgenology.— 1936,36, pp. 1–13 R. Barth, A. Soloway, R. Brugger. Boron neutron capture therapy of brain tumors: past history, current status, and future potential //Cancer Investigation.— 1996, 14 (6), pp. 534–550.

14. J. P. Pignol, P. Chauvel. Neutron capturing irradiation: principle, current results and perspectives //Bulletin du Cancer Radiotherapie.— 1995, 82, pp. 283–297.

15. A. Mill. Tumours in the neutron trap //New Scientist.— 1989, 18 Nov., pp. 56–59.

16. R. Barth, A. Soloway, R. Ferchild Bor neutron capture therapy of cancer, Science world,— 1990, 12, М: publishers “Mir”, p. 56–61.

17. L. E. Farr, W. H. Sweet, J. S. Robertson, S. G. Foster, H. B. Locksley, D. L. Sutherland, M. L. Mendelsohn, E. E. Stickey. Neutron capture therapy with boron in the treatment of glioblastoma multiform //American Journal of Rentgenology.— 1954, 71, pp. 279–293.

18. D. N. Slatkin. A history of boron neutron capture therapy of brain tumors //Brain 114.— 1991, pp. 1609–1629.

19. A. H. Soloway, H. Hatanaka, M. A. Davis. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds // Journal of Medicinal Chemistry.—1967, 10, pp. 714–717.

20. H. Hatanaka. Boron neutron capture therapy for tumors. H. Hatanaka (ed), Boron Neutron Capture Therapy for Tumors.— Nishimura, Niigata, Japan.— 1986, pp. 1–28.

21. A. H. Soloway, R. F. Barth, R. A. Gahbauer, Т. Е. Blue, J. H. Goodman. The rational and requirements for the development of boron neutron capture therapy of brain tumors // Journal of Neuro-Oncology, 1997,33, pp. 9–18.

22. A. H. Soloway, R. F. Barth, M. D. Carpenter. Advances in neutron capture therapy.— New York, Plenum Press.— 1993.

23. D. Gabel, R. Moss. Boron neutron capture therapy.— 1992, New York, Plenum Press.

24. Y. Mishima. Cancer neutron capture therapy.— New York, Plenum Press.— 1996.

25. R. F. Barth, A. H. Soloway, R. G. Fairchild, R. M. Brugger. Boron neutron capture therapy for cancer: Realities and prospects //Cancer.— 1992,70, pp. 2995–3007.

26. R. V. Dorn. Boron neutron capture therapy (BNCT): A radiation oncology perspective //International Journal of Radiation Oncology, Biology, Physics.— 1994, 28, pp. 1189–1201.

27. H. J. Weinmann, R. C. Brasch, W. R. Press, and G. E. Wesbey. Characteristics of Gadolinium-DTPA complex — A potential for NMR contrast agent //American Journal of Roentgenology.—1984,142 (3), pp. 619–624.

28. T. Matsumoto. Transport calculations of depth-dose distributions for gadolinium neutron capture therapy //Physics in Medicine and Biology.— 1992, 37 (1), pp. 155–162.

29. J. T. Masiakowski, J. L. Horton, L. J. Peters. Gadolinium neutron capture therapy for brain tumors: a computer study //Medical Physics.— 1992, Sep-Oct, 19, pp. 1277–1284.

30. K.— P. Cheng, K. Unlu, A. J. Teachout, N. M. Abdurrahman, B. W. Wehring. Gadolinium neutron capture therapy dosimetry measurements. Transactions of the American Nuclear Society.— 1995, Oct-Nov, 73, pp. 30–31.

31. B. J. Allen, B.J. McGregor, R. F. Martin. Neutron capture therapy with Gadolinium-157 // Strahlentherapie und Onkologie.— 1989, February/ March, Volume 165, No. 2/3, p. 156–158.

32. R. F. Martin, G. D’Cunha, M. Pardee, B.J. Allen. Induction of double-strand breaks following neutron capture by DNA-bound 157Gd //International Journal of Radiation Biology.— 1988, Aug, Vol. 54, no. 2, pp. 205–208.

33. R. F. Martin, G. D’Cunha, M. Pardee, B. J. Allen. Induction of DNA double-strand breaks by 157Gd neutron capture //Pigment Cell Research.— 1989, Jul-Aug, 2, pp. 330–332.

34. B. H. Laster, G. Shani, S. B. Kahl, L. Warkentien. The biological effects of Auger electrons compared to alpha-particles and Li ions //Acta Oncologica.— 1996, 35 (7), pp. 917–923.

35. J. Stepanek, Radiation spectrum of 158Gd and radial dose distribution. In Advances in Neutron Capture Therapy 2 (B. Larsson, J. Crawford and R. Weinreich, Eds.). Excerpta Medica, Int. Cong. Series 1132, Elsevier, Amsterdam, 1997.

36. C. K. C Wang, M. Sutton, T. M. Evans and B. H. Laster, A microdosimetric study of 10B (n, ) 7Li and 157Gd (n, ) reactions for neutron capture therapy. In Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium (A. T. Stelsen, M. G. Stabin and R. B. Sparks, Eds.), pp. 336–344. Report ORISE 99–0164, Oak Ridge Institute for Science and Education, Oak Ridge, TN, 1999.

37. Tim Goorley, Hooshang Nikjoo, Electron and Photon Spectra for Three Gadolinium-Based Cancer Therapy Approaches. Radiat. Res. 54, 556–563 (2000).

38. M. Rivard, J. Stepanek Methods to determine the fluorescence and Auger spectra due to decay of radionuclides or due to a single atomic-subshell ionization and comparisons with experiments Med. Phys. 27, 1544 (2000).

39. S. A. Klykov, S. P. Kapchigashev, V. I. Potetnya et al. Experimental determination of energy release in the neutron capture by gadolinium. Atomnaya Energiya, v.91, i.6, December 2001.

40. Abramov A.I., Kazanskyj Yu.A., Matusevich E.S. Basics of experimental methods of nuclear physics. Moscow. Energoatomizdat Publ. 1984, p.388.

41. Shih, J.L. and Brugger, R.M., 1992. Gadolinium as a neutron capture therapy gent.. Med Phys 19, 733–44.

42. Barnhart, J.L., Kuhnert, N., Bakan, D.A. and Berk, R.N., 1987. Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues. Magn Reson Imaging 5, 221–31.

43. Akine, Y., Tokita, N., Tokuuye, K., Satoh, M., Fukumori, Y., Tokumitsu, H., Kanamori, R., Kobayashi, T. and Kanda, K., 1992. Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules. J Cancer Res Clin Oncol 119, 71–3.

44. Miyamoto, M., Hirano, K., Ichikawa, H., Fukumori, Y., Akine, Y. and Tokuuye, K., 1999. Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters. Biol Pharm Bull 22, 1331–40.

45. Tokumitsu, H., Ichikawa, H. and Fukumori, Y., 1999. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res 16, 1830–5.

46. Tokumitsu, H., Hiratsuka, J., Sakurai, Y., Kobayashi, T., Ichikawa, H. and Fukumori, Y., 2000. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 150, 177–82.

47. Watanabe, T., Ichikawa, H. and Fukumori, Y., 2002. Tumor accumulation of gadolinium in lipid-nanoparticles intravenously injected for neutron-capture therapy of cancer. Eur J Pharm Biopharm 54, 119–24.

48. Proceedings of 14th International Congress on Neutron Capture Therapy, Chemistry and Pharmacology. Buenos Aires, Argentina, 25–29 October, 2010: 319–369.

49. Miyamoto M., Hirano K., Ichikawa H., Fukumori Y., Akine Y., Tokuuye K. “Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters”. Biol. Pharm. Bull. 22 (1999): 1331–40.

50. Miyamoto M., Ichikawa H., Fukumori Y., Akine Y. Tokuuye K. “Design and preparation of gadolinium-reservoir microcapsules for neutroncapture therapy by means of the Wurster process”. Chem. Pharm. Bull. 45 (1997.): 2043–50.

51. Khokhlov V. F., Yashkin P. N., Silin D. I., Lawaczeck R. “Neutron capture therapy with Gd-DTPA in tumor-bearing rats”. Plenum Press, New York, 1996: 865–869.

52. Khokhlov V. F., Korotkevich A. O., Malutina T. S., et al. “Biological evaluation of boron- and gadolinium-containing agents for NCT”. In Report E-94 of Eighth International Symposium on Neutron Capture Therapy for Cancer. La Jolla, California, USA, 13–18 September 1998.

53. Protection and recovery after radiation injury. Moscow. Nauka Publ. 1966.

54. Koblik Yu.N., Abdullaeva G.A., Kulabdullaev G.A., Kim A.A., Dzhuraeva G.T., Belasarov K.A., Kahharov Zh.N., Mavlyanov I.R. Canal of epithermal neutrons for medico-biological investigations on IYaF AN RUz reactor. Zhurnal Meditsinskaya fizika [Journal of Medical Physics].. 3, 51, 31. 2011.